Our Blog
The LAMP Study: What Is the Best Atropine Dose for Myopia Control?
Childhood myopia, also known as short-sightedness, is one of the most common eye conditions affecting children worldwide. If your child
The CRYO-ROP Study: The Landmark Trial That Changed Retinopathy of Prematurity Treatment
Retinopathy of prematurity (ROP) is one of the leading causes of childhood blindness in babies born prematurely. If your baby
The ATOM Study: Landmark Research on Atropine Eye Drops for Childhood Myopia
Childhood myopia, commonly known as short-sightedness, has become one of the fastest-growing eye health concerns worldwide. If your child has
The BEAT-ROP Study: A Breakthrough in Retinopathy of Prematurity
Retinopathy of prematurity (ROP) is a serious eye condition that can affect babies who are born prematurely. It develops when
The COMET Study: Does Corneal Cross-Linking Slow Keratoconus?
Keratoconus is a progressive eye condition in which your cornea, the clear front surface of your eye, gradually becomes thinner
The MARINA Study: How Anti-VEGF Therapy Changed Macular Degeneration Forever
Age-related macular degeneration (AMD) is one of the leading causes of vision loss in older adults. It affects your macula,
The ANCHOR Study: A Turning Point in Wet Macular Degeneration Treatment
Wet age-related macular degeneration (AMD) is one of the most serious causes of vision loss in older adults. If you
The DRCR.net Protocol T Study: Which Injection Works Best for Diabetic Macular Oedema?
Diabetic macular oedema (DMO) is one of the most common causes of vision loss in people with diabetes. If you
The AREDS2 Study: How Did It Change Eye Vitamin Recommendations?
Age-related macular degeneration (AMD) is one of the leading causes of vision loss in older adults. If you have AMD
The Age-Related Eye Disease Study (AREDS): A Landmark Study in Macular Degeneration
Age-related macular degeneration (AMD) is one of the leading causes of vision loss in older adults. If you develop AMD,
The Collaborative Initial Glaucoma Treatment Study (CIGTS): Surgery or Eye Drops First?
Glaucoma is a lifelong eye condition that requires careful treatment to help prevent irreversible vision loss. If you have glaucoma,
The Advanced Glaucoma Intervention Study (AGIS): What Did It Teach Us About Long-Term Glaucoma Care?
Glaucoma is a chronic eye condition that requires lifelong monitoring and management. Because damage to the optic nerve is usually
The Early Manifest Glaucoma Trial (EMGT): Does Early Treatment Make a Difference?
Glaucoma is one of the leading causes of irreversible blindness worldwide, often progressing slowly and without obvious symptoms during its
The Ocular Hypertension Treatment Study (OHTS): Can Glaucoma Be Prevented?
Glaucoma is one of the leading causes of irreversible vision loss worldwide, but it often develops gradually without noticeable symptoms
The Future of Eye Surgery: Innovations Expected in 2027
Eye surgery has advanced remarkably over the past few decades, transforming the way many eye conditions are diagnosed and treated.
The LAMP Study: What Is the Best Atropine Dose for Myopia Control?
Childhood myopia, also known as short-sightedness, is one of the most common eye conditions affecting children worldwide. If your child
The CRYO-ROP Study: The Landmark Trial That Changed Retinopathy of Prematurity Treatment
Retinopathy of prematurity (ROP) is one of the leading causes of childhood blindness in babies born prematurely. If your baby
The ATOM Study: Landmark Research on Atropine Eye Drops for Childhood Myopia
Childhood myopia, commonly known as short-sightedness, has become one of the fastest-growing eye health concerns worldwide. If your child has
The BEAT-ROP Study: A Breakthrough in Retinopathy of Prematurity
Retinopathy of prematurity (ROP) is a serious eye condition that can affect babies who are born prematurely. It develops when
The COMET Study: Does Corneal Cross-Linking Slow Keratoconus?
Keratoconus is a progressive eye condition in which your cornea, the clear front surface of your eye, gradually becomes thinner
The MARINA Study: How Anti-VEGF Therapy Changed Macular Degeneration Forever
Age-related macular degeneration (AMD) is one of the leading causes of vision loss in older adults. It affects your macula,
The ANCHOR Study: A Turning Point in Wet Macular Degeneration Treatment
Wet age-related macular degeneration (AMD) is one of the most serious causes of vision loss in older adults. If you
The DRCR.net Protocol T Study: Which Injection Works Best for Diabetic Macular Oedema?
Diabetic macular oedema (DMO) is one of the most common causes of vision loss in people with diabetes. If you
The AREDS2 Study: How Did It Change Eye Vitamin Recommendations?
Age-related macular degeneration (AMD) is one of the leading causes of vision loss in older adults. If you have AMD
The Age-Related Eye Disease Study (AREDS): A Landmark Study in Macular Degeneration
Age-related macular degeneration (AMD) is one of the leading causes of vision loss in older adults. If you develop AMD,
The Collaborative Initial Glaucoma Treatment Study (CIGTS): Surgery or Eye Drops First?
Glaucoma is a lifelong eye condition that requires careful treatment to help prevent irreversible vision loss. If you have glaucoma,
The Advanced Glaucoma Intervention Study (AGIS): What Did It Teach Us About Long-Term Glaucoma Care?
Glaucoma is a chronic eye condition that requires lifelong monitoring and management. Because damage to the optic nerve is usually
The Early Manifest Glaucoma Trial (EMGT): Does Early Treatment Make a Difference?
Glaucoma is one of the leading causes of irreversible blindness worldwide, often progressing slowly and without obvious symptoms during its
The Ocular Hypertension Treatment Study (OHTS): Can Glaucoma Be Prevented?
Glaucoma is one of the leading causes of irreversible vision loss worldwide, but it often develops gradually without noticeable symptoms
The Future of Eye Surgery: Innovations Expected in 2027
Eye surgery has advanced remarkably over the past few decades, transforming the way many eye conditions are diagnosed and treated.